IDx reached an exclusivity agreement with Topcon to sell its artificial intelligence-based diagnostic system with the Topcon NW400 robotic fundus camera.
The agreement grants exclusive rights to IDx in the United States as the only autonomous AI company permitted to sell its products with the Topcon NW400, a joint press release said. In turn, IDx will only use the NW400 camera with IDx-DR, the company’s autonomous AI diagnostic system that detects diabetic retinopathy in fundus images.
Michael D. Abramoff, MD, PhD, founder and CEO of IDx, pointed out the “ease (Read more...)
Uncategorized